[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Thyroid Function Test Market by Test Type (TSH Tests, T3 Tests, T4 Tests, and Other Tests) and End User (Diagnostic Laboratories, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

March 2020 | 206 pages | ID: TA7C6BEA94DDEN
Allied Market Research

US$ 5,370.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global thyroid function test market was valued at $1,190 million in 2018, and is projected to reach $1,807 million by 2026, registering a CAGR of 5.3% from 2019 to 2026.

Thyroid function test involves a series of blood tests used to measure adequacy of the levels of thyroid hormones. These blood tests can define whether the thyroid hormone production is normal, overactive, or underactive. It involves the different types of tests such as T3, T4, TSH, and T3RU.

The thyroid function test market is expected to witness significant growth during the forecast period owing to increase in prevalence of thyroid disorders, rise in awareness for early screening of disease, and wide presence of advanced diagnostic laboratories. In addition, early detection of the disease, increase in number of geriatric population, and rise in number of awareness campaigns in developing countries supportthe market growth. However, lack of insurance coverage for thyroid testing hampers the market growth.

The global thyroid function test market is segmented into test type, end user, and region. By test type, the market is classified into TSH tests, T3 tests, T4 TESTS, and others. According to end user, it is categorized into hospitals, diagnostic laboratories, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

By Test type
  • TSH Tests
  • T3 Tests
  • T4 Tests
  • Other Tests
By End user
  • Diagnostic Laboratories
  • Hospitals
  • Others
By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • Biomerieux
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin
  • F. Hoffmann-La Roche AG
  • KRONUS
  • Merck KGaA
  • Qualigen Inc.
  • ThermoFisher Scientific
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Cortez Diagnostics
      • Autobio Diagnostics
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
  1.3.1. List of key players profiled in the report
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. Key findings
  2.2.1. Top investment pockets
  2.2.2. Market player positioning, 2018
2.3. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key forces shaping thyroid function test industry/market
  3.2.1. Moderate power of suppliers
  3.2.2. High threat of new entrants
  3.2.3. High threat of substitution
  3.2.4. Moderate competitive rivalry
  3.2.5. Moderate bargaining power of buyers
3.3. Market dynamics
  3.3.1. Drivers
    3.3.1.1. Increase in prevalence of thyroid disorders
    3.3.1.2. Increase in number of geriatric population
    3.3.1.3. Surge in healthcare expenditure worldwide
  3.3.2. Restraint
    3.3.2.1. Lack of awareness in under developed nations
  3.3.3. Opportunities
    3.3.3.1. Growth opportunities in emerging markets
  3.3.4. Impact analysis

CHAPTER 4: THYROID FUNCTION TEST MARKET, BY TEST TYPE

4.1. Overview
  4.1.1. Market size and forecast
4.2. TSH tests
  4.2.1. Key market trends and opportunities
  4.2.2. Market size and forecast, by region
  4.2.3. Market analysis, by country
4.3. T3 Tests
  4.3.1. Key market trends and opportunities
  4.3.2. Market size and forecast, by region
  4.3.3. Market analysis, by country
4.4. T4 tests
  4.4.1. Key market trends and opportunities
  4.4.2. Market size and forecast, by region
  4.4.3. Market analysis, by country
4.5. Others
  4.5.1. Key market trends and opportunities
  4.5.2. Market size and forecast, by region
  4.5.3. Market analysis, by country

CHAPTER 5: THYROID FUNCTION TEST MARKET, BY END USER

5.1. Overview
  5.1.1. Market size and forecast
5.2. Diagnostic Laboratories
  5.2.1. Market size and forecast
  5.2.2. Market analysis, by country
5.3. Hospitals
  5.3.1. Market size and forecast
  5.3.2. Market analysis, by country
5.4. Others
  5.4.1. Market size and forecast
  5.4.2. Market analysis, by country

CHAPTER 6: THYROID FUNCTION TEST MARKET, BY REGION

6.1. Overview
  6.1.1. Market size and forecast
6.2. North America
  6.2.1. Key market trends, growth factors, and opportunities
  6.2.2. Market size and forecast, by country
    6.2.2.1. U.S.
      6.2.2.1.1. U.S. thyroid function test market, by test type
      6.2.2.1.2. U.S. thyroid function test market, by end user
    6.2.2.2. Canada
      6.2.2.2.1. Canada thyroid function test market, by test type
      6.2.2.2.2. Canada thyroid function test market, by end user
    6.2.2.3. Mexico
      6.2.2.3.1. Mexico thyroid function test market, by test type
      6.2.2.3.2. Mexico thyroid function test market, by end user
  6.2.3. North America market size and forecast, by test type
  6.2.4. North America thyroid function test market, by end user
6.3. Europe
  6.3.1. Key market trends, growth factors, and opportunities
  6.3.2. Market size and forecast, by country
    6.3.2.1. Germany
      6.3.2.1.1. Germany thyroid function test market, by test type
      6.3.2.1.2. Germany thyroid function test market, by end user
    6.3.2.2. France
      6.3.2.2.1. France thyroid function test market, by test type
      6.3.2.2.2. France thyroid function test market, by end user
    6.3.2.3. UK
      6.3.2.3.1. UK thyroid function test market, by test type
      6.3.2.3.2. UK thyroid function test market, by end user
    6.3.2.5. Italy
      6.3.2.5.1. Italy thyroid function test market, by test type
      6.3.2.5.2. Italy thyroid function test market, by end user
    6.3.2.6. Spain
      6.3.2.6.1. Spain thyroid function test market, by test type
      6.3.2.6.2. Spain thyroid function test market, by end user
    6.3.2.7. Rest of Europe
      6.3.2.7.1. Rest of Europe thyroid function test market, by test type
      6.3.2.7.2. Rest of Europe thyroid function test market, by end user
  6.3.3. Europe market size and forecast, by test type
  6.3.4. Europe thyroid function test market, by end user
6.4. Asia-Pacific
  6.4.1. Key market trends, growth factors, and opportunities
  6.4.2. Market size and forecast, by country
    6.4.2.1. Japan
      6.4.2.1.1. Japan thyroid function test market, by test type
      6.4.2.1.2. Japan thyroid function test market, by end user
    6.4.2.2. China
      6.4.2.2.1. China thyroid function test market, by test type
      6.4.2.2.2. China thyroid function test market, by end user
    6.4.2.3. Australia
      6.4.2.3.1. Australia thyroid function test market, by test type
      6.4.2.3.2. Australia thyroid function test market, by end user
    6.4.2.5. India
      6.4.2.5.1. India thyroid function test market, by test type
      6.4.2.5.2. India thyroid function test market, by end user
    6.4.2.6. South Korea
      6.4.2.6.1. South Korea thyroid function test market, by test type
      6.4.2.6.2. South Korea thyroid function test market, by end user
    6.4.2.7. Rest of Asia-Pacific
      6.4.2.7.1. Rest of Asia-Pacific thyroid function test market, by test type
      6.4.2.7.2. Rest of Asia-Pacific thyroid function test market, by end user
  6.4.3. Asia-Pacific market size and forecast, by test type
  6.4.4. Asia-Pacific thyroid function test market, by end user
6.5. LAMEA
  6.5.1. Key market trends, growth factors, and opportunities
  6.5.2. Market size and forecast, by country
    6.5.2.1. Brazil
      6.5.2.1.1. Brazil thyroid function test market, by test type
      6.5.2.1.2. Brazil thyroid function test market, by end user
    6.5.2.3. Saudi Arabia
      6.5.2.3.1. Saudi Arabia thyroid function test market, by test type
      6.5.2.3.2. Saudi Arabia thyroid function test market, by end user
    6.5.2.4. South Africa
      6.5.2.4.1. South Africa thyroid function test market, by test type
      6.5.2.4.2. South Africa thyroid function test market, by end user
    6.5.2.5. Rest of LAMEA
      6.5.2.5.1. Rest of LAMEA thyroid function test market, by test type
      6.5.2.5.2. Rest of LAMEA thyroid function test market, by end user
  6.5.3. LAMEA market size and forecast, by test type
  6.5.4. LAMEA thyroid function test market, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories
  7.1.1. Company overview
  7.1.2. Company snapshot
  7.1.3. Operating business segments
  7.1.4. Product portfolio
  7.1.5. Business performance
7.2. Biomerieux
  7.2.1. Company overview
  7.2.2. Company snapshot
  7.2.3. Operating business segments
  7.2.4. Product portfolio
  7.2.5. Business performance
7.3. Danaher Corporation
  7.3.1. Company overview
  7.3.2. Company snapshot
  7.3.3. Operating business segments
  7.3.4. Product portfolio
  7.3.5. Business performance
7.4. Diagnostic Automation/Cortez Diagnostics Inc.
  7.4.1. Company overview
  7.4.2. Company snapshot
  7.4.3. Operating business segments
  7.4.4. Product portfolio
7.5. DiaSorin
  7.5.1. Company overview
  7.5.2. Company snapshot
  7.5.3. Operating business segments
  7.5.4. Product portfolio
  7.5.5. Business performance
7.6. F. Hoffmann-La Roche AG
  7.6.1. Company overview
  7.6.2. Company snapshot
  7.6.3. Operating business segments
  7.6.4. Product portfolio
  7.6.5. Business performance
7.7. KRONUS
  7.7.1. Company overview
  7.7.2. Company snapshot
  7.7.3. Operating business segments
  7.7.4. Product portfolio
7.8. Merck KGaA
  7.8.1. Company overview
  7.8.2. Company snapshot
  7.8.3. Operating business segments
  7.8.4. Product portfolio
  7.8.5. Business performance
7.9. Qualigen Inc.
  7.9.1. Company overview
  7.9.2. Company snapshot
  7.9.3. Operating business segments
  7.9.4. Product portfolio
7.10. ThermoFisher Scientific
  7.10.1. Company overview
  7.10.2. Company snapshot
  7.10.3. Operating business segments
  7.10.4. Product portfolio
  7.10.5. Business performance

LIST OF TABLES

TABLE 01. GLOBAL THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026 ($MILLION)
TABLE 02. TSH TESTS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. T3 TESTS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. T4 TESTS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. OTHERS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06. GLOBAL THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 07. DIAGNOSTIC LABORATORIES THYROID FUNCTION TEST MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. HOSPITALS THYROID FUNCTION TEST MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09. OTHERS THYROID FUNCTION TEST MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. THYROID FUNCTION TEST MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 11. NORTH AMERICA THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 12. U.S. THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 13. U.S. THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 14. CANADA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 15. CANADA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 16. MEXICO THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 17. MEXICO THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 18. NORTH AMERICA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 19. NORTH AMERICA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 20. EUROPE THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 21. GERMANY THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 22. GERMANY THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 23. FRANCE THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 24. FRANCE THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 25. UK THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 26. UK THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 27. ITALY THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 28. ITALY THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 29. SPAIN THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 30. SPAIN THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 31. REST OF EUROPE THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 32. REST OF EUROPE THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 33. EUROPE THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 34. EUROPE THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 35. ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 36. JAPAN THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 37. JAPAN THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 38. CHINA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 39. CHINA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 40. AUSTRALIA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 41. AUSTRALIA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 42. INDIA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 43. INDIA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 44. SOUTH KOREA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 45. SOUTH KOREA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 46. REST OF ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 47. REST OF ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 48. ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 49. ASIA-PACIFIC THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 50. LAMEA THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 51. BRAZIL THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 52. BRAZIL THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 53. SAUDI ARABIA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 54. SAUDI ARABIA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 55. SOUTH AFRICA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 56. SOUTH AFRICA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 57. REST OF LAMEA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 58. REST OF LAMEA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 59. LAMEA THYROID FUNCTION TEST MARKET, BY TEST TYPE, 2018–2026
TABLE 60. LAMEA THYROID FUNCTION TEST MARKET, BY END USER, 2018–2026
TABLE 61. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 62. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 63. ABBOTT LABORATORIES PLC: PRODUCT PORTFOLIO
TABLE 64. BIOMERIEUX: COMPANY SNAPSHOT
TABLE 65. BIOMERIEUX: OPERATING SEGMENTS
TABLE 66. BIOMERIEUX: PRODUCT PORTFOLIO
TABLE 67. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 68. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 69. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 70. DACDI: COMPANY SNAPSHOT
TABLE 71. DACDI: OPERATING SEGMENTS
TABLE 72. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 73. DIASORIN: COMPANY SNAPSHOT
TABLE 74. DIASORIN: OPERATING SEGMENTS
TABLE 75. DIASORIN: PRODUCT PORTFOLIO
TABLE 76. ROCHE: COMPANY SNAPSHOT
TABLE 77. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.: OPERATING SEGMENTS
TABLE 78. DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 79. KRONUS.: COMPANY SNAPSHOT
TABLE 80. KRONUS.: OPERATING SEGMENTS
TABLE 81. KRONUS: PRODUCT PORTFOLIO
TABLE 82. MERCK KGAA: COMPANY SNAPSHOT
TABLE 83. MERCK KGAA INC.: OPERATING SEGMENTS
TABLE 84. MERCK KGAA INC.: PRODUCT PORTFOLIO
TABLE 85. QUALIGEN INC.: COMPANY SNAPSHOT
TABLE 86. QUALIGEN INC.: PRODUCT SEGMENTS
TABLE 87. QUALIGEN INC.: PRODUCT PORTFOLIO
TABLE 88. THERMOFISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 89. THERMOFISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 90. THERMOFISHER SCIENTIFIC: PRODUCT PORTFOLIO:

LIST OF FIGURES

FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. MARKET PLAYER POSITIONING, 2018
FIGURE 03. GLOBAL THYROID FUNCTION TEST MARKET SEGMENTATION
FIGURE 04. IMPACT ANALYSIS
FIGURE 05. COMPARATIVE ANALYSIS OF TSH TESTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 06. COMPARATIVE ANALYSIS OF T3 TESTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 07. COMPARATIVE ANALYSIS OF T4 TESTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 08. COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 09. COMPARATIVE ANALYSIS OF DIAGNOSTIC LABORATORIES THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 10. COMPARATIVE ANALYSIS OF HOSPITALS THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF OTHERS THYROID FUNCTION TEST MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 12. U.S. THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 13. CANADA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 14. MEXICO THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 15. GERMANY THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 16. FRANCE THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 17. UK THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 18. ITALY THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 19. SPAIN THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 20. REST OF EUROPE THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 21. JAPAN THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 22. CHINA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 23. AUSTRALIA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 24. INDIA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 25. SOUTH KOREA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 27. BRAZIL THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 28. SAUDI ARABIA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 29. SOUTH AFRICA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 30. REST OF LAMEA THYROID FUNCTION TEST MARKET, 2018–2026 ($MILLION)
FIGURE 31. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 32. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 33. DANAHER CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 34. DANAHER CORPORATION.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 35. DANAHER CORPORATION INC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 36. DIASORIN: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. DIASORIN: REVENUE SHARE BY REGION, 2018(%)
FIGURE 38. ROCHE: NET SALES, 2017–2018 ($MILLION)
FIGURE 39. ROCHE: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 40. ROCHE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 41. MERCK KGAA: NET SALES, 2016–2018 ($MILLION)
FIGURE 42. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 43. MERCK KGAA: REVENUE SHARE BY REGION, 2018(%)
FIGURE 44. THERMOFISHER SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 45. THERMOFISHER SCIENTIFIC: REVENUE SHARE BY SEGMENTS, 2018(%)
FIGURE 46. THERMOFISHER SCIENTIFIC: REVENUE SHARE BY REGION, 2018 (%)


More Publications